
Regeneron secures tariff relief and avoids future US government pricing mandates until 2029
At the Bank of America Healthcare Conference 2026, Regeneron Pharmaceuticals announced a new agreement granting them tariff relief and exemption from future US government pricing mandates through January 2029. This deal applies only to products wholl...

